Agentix (AGTX) Other financing activities (2017 - 2018)
Agentix's (AGTX) quarterly Other financing activities came in at $20000.0 in Q4 2018, little changed YoY from $20000.0 in Q4 2017, and little changed on a QoQ basis from $20000.0 in Q4 2017.
Agentix (AGTX) Other financing activities (2017 - 2018) Analysis & Trends
Agentix (AGTX) has 2 years of Other financing activities data on file, last reported at $20000.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2018 | 20,000.00 |
| Nov 30, 2018 | 20,000.00 |
| Nov 30, 2017 | 20,000.00 |
| Nov 30, 2017 | 20,000.00 |